Literature DB >> 7544577

Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.

E A Martinson1, S Scheible, A Greinacher, P Presek.   

Abstract

Blood platelets contain phospholipase D (PLD) that is rapidly activated following platelet stimulation. It is currently unclear, however, where PLD fits into the signalling cascade that leads to aggregation and secretion. Therefore we investigated the mechanism of activation of PLD in human platelets, using the formation of the PLD-specific product phosphatidylethanol as a measure of PLD activity. PLD was activated by a number of platelet agonists that also cause the activation of protein kinase C, including thrombin, collagen, the Ca2+ ionophore A23187 and the thromboxane A2-mimetic U46619. Phorbol 12-myristate 13-acetate (PMA), a direct activator of protein kinase C, also increased PLD activity. A selective inhibitor of protein kinase C, Ro-31-8220, totally blocked the stimulation of PLD by thrombin or PMA under conditions in which it also inhibited phosphorylation of pleckstrin, the major protein kinase C substrate in platelets. Ro-31-8220 additionally inhibited A23187-stimulated PLD activity, indicating that Ca2+ activation of PLD also occurs via a protein kinase C-dependent pathway. In the presence of the fibrinogen antagonist peptide RGDS, which inhibits fibrinogen binding to integrin alpha IIb beta 3 and allows little or no aggregation to occur, thrombin- and PMA-stimulated PLD activity was still observed, indicating that PLD activation is not simply a consequence of platelet aggregation. Furthermore, these agonists were able to stimulate PLD in platelets from a Glanzmann's thrombasthenia type I patient lacking the integrin alpha IIb beta 3 complex, which indicates that activation of PLD is also independent of the recruitment of integrin alpha IIb beta 3. Taken together, our results show that PLD is activated by a pathway involving protein kinase C, and suggest that PLD might be involved in signal transduction events occurring upstream of integrin alpha IIb beta 3 activation and fibrinogen binding, which are prerequisites for full platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544577      PMCID: PMC1135941          DOI: 10.1042/bj3100623

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

Review 1.  The dynamic regulation of integrin adhesiveness.

Authors:  M S Diamond; T A Springer
Journal:  Curr Biol       Date:  1994-06-01       Impact factor: 10.834

2.  Integrin-dependent protein dephosphorylation on tyrosine induced by activation of the thrombin receptor in human platelets.

Authors:  K Luber; W Siess
Journal:  Cell Signal       Date:  1994-03       Impact factor: 4.315

3.  Phospholipase D: a downstream effector of ARF in granulocytes.

Authors:  S Cockcroft; G M Thomas; A Fensome; B Geny; E Cunningham; I Gout; I Hiles; N F Totty; O Truong; J J Hsuan
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

4.  Heparin-associated thrombocytopenia: the effects of various intravenous IgG preparations on antibody mediated platelet activation--a possible new indication for high dose i.v. IgG.

Authors:  A Greinacher; U Liebenhoff; V Kiefel; P Presek; C Mueller-Eckhardt
Journal:  Thromb Haemost       Date:  1994-05       Impact factor: 5.249

Review 5.  Phosphatidylcholine breakdown and signal transduction.

Authors:  J H Exton
Journal:  Biochim Biophys Acta       Date:  1994-04-14

6.  ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity.

Authors:  H A Brown; S Gutowski; C R Moomaw; C Slaughter; P C Sternweis
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

7.  Identification, partial purification, and characterization of a novel phospholipid-dependent and fatty acid-activated protein kinase from human platelets.

Authors:  W A Khan; G C Blobe; A L Richards; Y A Hannun
Journal:  J Biol Chem       Date:  1994-04-01       Impact factor: 5.157

8.  v-Src activates a unique phospholipase D activity that can be distinguished from the phospholipase D activity activated by phorbol esters.

Authors:  J Song; D A Foster
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

Review 9.  Signalling properties of lysophosphatidic acid.

Authors:  M E Durieux; K R Lynch
Journal:  Trends Pharmacol Sci       Date:  1993-06       Impact factor: 14.819

10.  Activation of actin polymerization by phosphatidic acid derived from phosphatidylcholine in IIC9 fibroblasts.

Authors:  K S Ha; J H Exton
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

View more
  6 in total

1.  Acute inhibition of superoxide formation and Rac1 activation by nitric oxide and iloprost in human vascular smooth muscle cells in response to the thromboxane A2 analogue, U46619.

Authors:  S Muzaffar; N Shukla; M Bond; G Sala-Newby; G D Angelini; A C Newby; J Y Jeremy
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-04-16       Impact factor: 4.006

2.  Activation of the small GTPase Ral in platelets.

Authors:  R M Wolthuis; B Franke; M van Triest; B Bauer; R H Cool; J H Camonis; J W Akkerman; J L Bos
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

Review 3.  Platelet receptor signaling in thrombus formation.

Authors:  David Stegner; Bernhard Nieswandt
Journal:  J Mol Med (Berl)       Date:  2010-11-07       Impact factor: 4.599

4.  Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1.

Authors:  Margitta Elvers; David Stegner; Ina Hagedorn; Christoph Kleinschnitz; Attila Braun; Marijke E J Kuijpers; Michael Boesl; Qin Chen; Johan W M Heemskerk; Guido Stoll; Michael A Frohman; Bernhard Nieswandt
Journal:  Sci Signal       Date:  2010-01-05       Impact factor: 8.192

5.  Activation of LA-N-2 cell phospholipase D by amyloid beta protein (25-35).

Authors:  I N Singh; G Sorrentino; J N Kanfer
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

6.  Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.

Authors:  S F Moore; R W Hunter; I Hers
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.